V
VivoSim Labs, Inc. (VIVS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$0.12
-0.00 (-2.91%)
Market Cap: $2.51M
Last updated: Nov 17, 2026 at 4:10 PM ET
VivoSim Labs, Inc. (VIVS) Valuation Multiples
VivoSim Labs (VIVS) trades at 14.6x sales and 0.3x book value. Its P/B of 0.3x is below its 5-year median of 1.3x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | N/A |
| Price to sales | 14.6x |
| Price to book | 0.3x |
| PEG | N/A |
Historical Medians
Against its 10-year medians, its P/B is 90.0% below 3.0x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/B | 0.3x | 1.3x | 3.0x |
Valuation History
Over the 6 of the 10 year ends shown that have a P/S, its P/S ranged from 4.3x in 2019 to 81.1x in 2016.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $1.81 | 1.7x | 25.7x | 1.1x |
| 2024 | $5.52 | N/A | N/A | 1.2x |
| 2023 | $13.33 | N/A | 33.1x | 1.6x |
| 2022 | $16.93 | N/A | N/A | 6.6x |
| 2021 | $43.58 | N/A | N/A | 12.1x |
| 2020 | $147.66 | N/A | N/A | 48.8x |
| 2019 | $86.43 | N/A | 4.3x | 1.6x |
| 2018 | $229.80 | N/A | 30.6x | 3.1x |
| 2017 | $321.73 | N/A | 32.7x | 3.0x |
| 2016 | $813.93 | N/A | 81.1x | 4.8x |
Frequently Asked Questions About VIVS
What is VIVS's price to sales ratio?
VivoSim Labs has a price to sales ratio of 14.6x.
VIVS pages: Overview, Charting, Earnings, Financials, Statistics, Valuation, Competitors